Influence of parathyroid hormone, calcitonin, 1,25(OH)2 cholecalciferol, calcium, and the calcium ionophore A23187 on erythrocyte morphology and blood viscosity

Journal of Laboratory and Clinical Medicine

Volumn 135, Issue 4, 2000, Pages 347-352

  Mark, Michael ^a,b   Walter, Roland ^a,b   Harris, Llinos G ^a,b   Reinhart, Walter H ^a,b  

^a KANTONSSPITAL   (Switzerland)

^b AO RESEARCH INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0034006283     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2000.105290     Document Type: Article

References (38)

1. 1. Akmal M, Telfer N, Ansari AN, Massry SG. Erythrocyte survival in chronic renal failure. Role of secondary hyperparathyroidism. J Clin Invest 1985;76:1695-8.
2. 2. Saltissi D, Carter GD. Association of secondary hyperparathyroidism with red cell survival in chronic haemodialysis patients. Clin Sci 1985;68:29-33.
3. 3. Bogin E, Massry SG, Levi J, Djaldeti M, Bristol G, Smith J. Effect of parathyroid hormone on osmotic fragility of human erythrocytes. J Clin Invest 1982;69:1017-25.
4. 4. Wu SG, Jeng FR, Wei SY, Su CZ, Chung TC, Chang WJ, et al. Red blood cell osmotic fragility in chronically hemodialyzed patients. Nephron 1998;78:28-32.
5. 5. Docci D, Turci F, Baldrati L. Lack of relation between secondary hyperparathyroidism and red blood cell osmotic fragility in chronic renal failure. Nephron 1985;41:241-5.
6. 6. Foulks CJ, Mills GM, Wright LF. Parathyroid hormone and anaemia: an erythrocyte osmotic fragility study in primary and secondary hyperparathyroidism. Postgrad Med J 1989;65:136-9.
7. 7. Brautbar N, Chakraborty J, Coats J, Massry SG. Calcium, parathyroid hormone and phospholipid turnover of human red blood cells. Miner Electrolyte Metab 1985;11:111-6.
8. 8. Dominiczak AF, Lyall F, Morton JJ, Dargie HJ, Boyle IT, Tune TT, et al. Blood pressure, left ventricular mass and intracellular calcium in primary hyperparathyroidism. Clin Sci 1990;78:127-32.
9. 9. Baksi SN. Hypotensive action of parathyroid hormone in hypoparathyroid and hyperparathyroid rats. Hypertension 1988;11:509-13.
10. 10. Shane E, Mancini D, Aaronson K, Silverberg SJ, Seibel MJ, Addesso V, et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 1997;103:197-207.
11. 11. Schmid C, Kiowski W. Hyperparathyroidism in congestive heart failure. Am J Med 1998;104:508-9.
12. 12. Burchard KW, Gann DS, Colliton J, Forster J. Ionized calcium, parathormone, and mortality in critically ill surgical patients. Ann Surg 1990;212:543-50.
13. 13. Carlstedt F, Lind L, Wide L, Lindahl B, Hänni A, Rastad J, et al. Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department. Eur J Clin Invest 1997;27:977-81.
14. 14. Hedbäck G, Odén A. Increased risk of death from primary hyperparathyroidism: an update. Eur J Clin Invest 1998;28: 271-6.
15. 15. Lind L, Bucht E, Ljunghall S. Pronounced elevation in circulating calcitonin in critical care patients is related to the severity of illness and survival. Intensive Care Med 1995; 21:63-6.
16. 16. Bukoski RD, Ishibashi K, Bian K. Vascular actions of the calcium-regulating hormones. Semin Nephrol 1995;15: 536-49.
17. 17. Muff R, Born W, Fischer JA. Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions. Eur J Endocrinol 1995;133:17-20.
18. 18. Stanley JC, Martin JL, Barron ME, Lovick AHJ, Nelson RJ, Richards HK, et al. A study of the cardiovascular and cerebrovascular effects of calcitonin gene-related peptide in human volunteers. J Physiol 1990;427:33P.
19. 19. Holzer P, Guth PH. Neuropeptide control of gastric mucosal blood flow: increase by calcitonin gene-related peptide and vasoactive intestinal peptide, but not substance P and neurokinin A. Circ Res 1991;68:100-5.
20. 20. Reichel H, Koeffler HP, Norman AW. The role of the vitamin D endocrine system in health and disease. N Engl J Med 1989;320:980-91.
21. 21. Meiselman HJ. Rheology of shape-transformed human red cells. Biorheology 1978;15:225-37.
22. 22. Reinhart WH, Chien S. Red cell rheology in stomatocyte-echinocyte transformation: roles of cell geometry and cell shape. Blood 1986;67:1110-8.
23. 23. Reinhart WH, Singh-Marchetti M, Straub PW. The influence of erythrocyte shape on suspension viscosities. Eur J Clin Invest 1992;22:38-44.
24. 24. Chien S. Biophysical behavior of red cells in suspension. In: Surgenor MacN, ed. The red blood cell. New York: Academic Press; 1975. p. 1031-133.
25. 25. Bessis M. Red cell shapes. An illustrated classification and its rationale. Nouv Rev Franç Hematol 1972;6:721-46.
26. 26. Ferrell JE, Huestis WH. Phosphoinositide metabolism and the morphology of human erythrocytes. J Cell Biol 1984; 98:1992-8.
27. 27. Richards RG, Gwynn IA. Backscattered electron imaging of the undersurface of resin-embedded cells by field emission scanning electron microscopy. J Microsc 1995; 177:43-52.
28. 28. Raess BU, Keenan CE. Characterization of a phenylglyoxal-sensitive passive Ca2+ permeability in human erythrocytes. J Membrane Biol 1996;151:45-51.
29. 29. White JG. Effects of an ionophore, A23187, on the surface morphology of normal erythrocytes. Am J Pathol 1974;3: 507-14.
30. 30. Reinhart WH, Chien S. Echinocyte-stomatocyte transformation and shape control of human red blood cells. Morphological aspects. Am J Hematol 1987;24:1-14.
31. 31. Zaidi A, Khan MT, Mirza M, Ahmad I, Saleemuddin M. Studies on the differential morphological alterations in human and goat erythrocytes against ATP depletion and Ca(2+)-induced stresses. Biochem Mol Biol Int 1995;37: 517-26.
32. 32. Lin S, Yang E, Huestis WH. Relationship of phospholipid distribution to shape change in calcium-crenated and recovered human erythrocytes. Biochemistry 1994;33:7337-44.
33. 33. Test ST, Mitsuyoshi J. Activation of the alternative pathway of complement by calcium-loaded erythrocytes resulting from loss of membrane phospholipid asymmetry. J Lab Clin Med 1997;130:169-82.
34. 34. de Jong K, Geldwerth D, Kuypers FA. Oxidative damage does not alter membrane phospholipid asymmetry in human erythrocytes. Biochemistry 1997;36:6768-76.
35. 35. Friederichs E, Meiselman HJ. Effects of calcium permeabilization on RBC rheologic behavior. Biorheology 1994;31: 207-15.
36. 36. Minetti G, Piccinini G, Balduini C, Seppi C, Brovelli A. Tyrosine phosphorylation of band 3 protein in Ca2+/A23187-treated human erythrocytes. Biochem J 1996;320:445-50.
37. 37. Tu YP, Feng C, Xu H, Guang ZY, Lu QW, Yang FY. Transmembrane Ca2+ gradient is essential for high anion transport activity of human erythrocytes. Biosci Rep 1996;16:299-311.
38. 38. Baerlocher GM, Beer JH, Owen GRh, Meiselman HJ, Reinhart WH. The anti-neoplastic drug 5-fluorouracil produces echinocytosis and affects blood rheology. Br J Haematol 1997;99:426-32.